What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Coccidiosis in Calves: Eimeria Species, Clinical Signs, and Anticoccidial Treatment

Introduction

Coccidiosis is a protozoal enteric disease of calves caused by apicomplexan parasites of the genus Eimeria. Among the 13 or more species that infect cattle, Eimeria bovis and Eimeria zuernii are the most pathogenic and economically significant [1, 2]. The disease is characterized by diarrhea, dehydration, weight loss, and occasionally death, particularly in calves between three weeks and six months of age [3]. Subclinical infections are common and contribute to reduced growth performance and increased susceptibility to secondary infections [4]. This article provides a detailed review of the etiologic agents, clinical presentation, diagnostic methods (with emphasis on fecal flotation), and anticoccidial treatment options including toltrazuril and amprolium. Cross-references to related parasitic conditions such as Fasciolosis in Cattle and Sheep and Cryptosporidiosis in Neonatal Ruminants are provided where relevant.

Etiology and Life Cycle

Bovine coccidiosis is caused by host-specific Eimeria species that undergo both asexual and sexual reproduction within the intestinal epithelium [5]. The life cycle begins when calves ingest sporulated oocysts from contaminated feed, water, or bedding. Each sporulated oocyst contains four sporocysts, each with two sporozoites [6]. After excystation in the small intestine, sporozoites invade enterocytes and undergo merogony (asexual multiplication). For E. bovis, merogony occurs in the ileum and cecum, producing large first-generation meronts containing up to 120,000 merozoites [7]. E. zuernii undergoes merogony in the colon and cecum [8]. Subsequent generations of merogony are followed by gametogony (sexual stage) and oocyst formation. Unsporulated oocysts are shed in feces and sporulate in the environment under favorable conditions (20-30 degrees Celsius, high humidity) within 1-3 days [9].

The prepatent period for E. bovis is 15-21 days, and for E. zuernii it is 14-18 days [10]. Oocyst shedding can persist for weeks, leading to heavy environmental contamination. The high reproductive potential of these parasites explains the rapid amplification of infection in confined calf housing [11].

Clinical Signs and Pathophysiology

Clinical coccidiosis typically occurs in calves aged 3-8 weeks, although older animals can be affected under high challenge conditions [12]. The severity of disease depends on the infective dose, species virulence, host immunity, and concurrent stressors such as weaning, transport, or dietary changes [13].

Acute Disease

Acute coccidiosis is characterized by profuse, watery diarrhea that may contain mucus and streaks of blood [14]. Tenesmus is common, and affected calves often exhibit a tucked-up abdomen and arched back. Dehydration, anorexia, and depression develop rapidly. In severe cases, hemorrhagic diarrhea and hypoproteinemia lead to weakness and recumbency [15]. Mortality can reach 10-20% in untreated outbreaks [16].

Subclinical Disease

Subclinical infections are more prevalent than clinical cases. They manifest as reduced feed intake, impaired weight gain, and uneven growth within a cohort [17]. Fecal oocyst counts may be high without overt diarrhea. Subclinical coccidiosis is a major contributor to economic losses in veal and dairy operations [18].

Pathophysiology

The pathological changes are driven by the destruction of intestinal epithelial cells during merogony and gametogony. E. bovis first-generation meronts can occupy the entire villus, causing villous atrophy and crypt hyperplasia [19]. E. zuernii infection leads to colonic mucosal erosion and inflammation. Disruption of the epithelial barrier results in malabsorption, osmotic diarrhea, and protein-losing enteropathy [20]. Secondary bacterial overgrowth, particularly by Clostridium perfringens, can exacerbate the clinical picture [21].

Diagnosis

Accurate diagnosis relies on a combination of clinical history, necropsy findings, and laboratory confirmation. Differential diagnoses include viral enteritis (bovine rotavirus, coronavirus), bacterial infections (Salmonella spp., Mycobacterium avium subsp. paratuberculosis), and other protozoal diseases such as cryptosporidiosis [22].

Fecal Flotation and Oocyst Counting

The cornerstone of antemortem diagnosis is fecal flotation using a saturated salt or sugar solution (specific gravity 1.20-1.30) [23]. Oocysts of Eimeria spp. are ovoid, 15-30 micrometers in length, and contain a distinct polar granule. E. bovis oocysts are ellipsoidal (23-34 x 17-23 micrometers) with a smooth wall; E. zuernii oocysts are subspherical (18-22 x 15-18 micrometers) [24]. Quantitative flotation using a McMaster counting chamber allows estimation of oocysts per gram (OPG) of feces. Counts above 5,000 OPG are often associated with clinical disease, but lower counts can still cause subclinical effects [25]. Flotation sensitivity is improved by using centrifugation and coverslip examination [26].

Molecular Diagnostics

Polymerase chain reaction (PCR) assays targeting the 18S ribosomal RNA gene or internal transcribed spacer (ITS-1) region enable species-level identification [27]. Quantitative PCR (qPCR) can provide accurate quantification of oocyst DNA and is more sensitive than microscopy for low-level shedding [28]. Multiplex PCR panels that differentiate E. bovis, E. zuernii, and other species are available for research and reference laboratories [29]. For a detailed discussion of qPCR applications, see Coccidiosis in Calves: Eimeria Species, Pathophysiology of Diarrhea, and Diagnosis Using Quantitative PCR and Fecal Oocyst Counts.

Necropsy Findings

Gross lesions include thickening and hyperemia of the ileal, cecal, and colonic mucosa. Petechial hemorrhages and diphtheritic membranes may be present. Histopathology reveals meronts and gamonts within enterocytes, villous atrophy, and inflammatory infiltrates [30].

Anticoccidial Treatment

Treatment aims to reduce oocyst shedding, alleviate clinical signs, and prevent mortality. Two compounds are widely used in calves: toltrazuril and amprolium. Other agents such as decoquinate and sulfonamides have been used historically but are less common today [31].

Toltrazuril

Toltrazuril is a triazinone derivative that interferes with mitochondrial respiration in apicomplexan parasites [32]. It is active against both asexual and sexual stages of Eimeria spp. and has a prolonged half-life, allowing a single oral dose (15 mg/kg body weight) to provide therapeutic and metaphylactic effects [33]. Studies have shown that toltrazuril reduces oocyst shedding by over 90% and improves weight gain in treated calves compared to untreated controls [34, 35]. It is particularly effective when administered early in the course of infection, before severe mucosal damage occurs [36]. Toltrazuril is also used in combination with management measures to control outbreaks in group-housed calves [37].

Amprolium

Amprolium is a thiamine analogue that competitively inhibits thiamine uptake in coccidian parasites [38]. It is administered orally at 10 mg/kg body weight daily for 5 days, or as a higher dose (20 mg/kg) for 5 days in severe cases [39]. Amprolium is effective against the asexual stages of Eimeria but has limited activity against mature gamonts and oocysts [40]. It reduces clinical signs and oocyst output, but repeated dosing is required. Prolonged use can lead to thiamine deficiency in calves, manifesting as polioencephalomalacia [41]. Therefore, treatment duration should not exceed 5 days.

Comparative Efficacy

A meta-analysis of controlled trials found that toltrazuril was superior to amprolium in reducing oocyst counts and improving clinical scores [42]. However, amprolium remains a cost-effective option for mild outbreaks or when toltrazuril is unavailable. Resistance to both drugs has been reported in poultry coccidiosis but is less documented in cattle [43]. Rotation of anticoccidials and adherence to label doses are recommended to delay resistance development.

Supportive Therapy

Supportive care includes fluid and electrolyte replacement, nonsteroidal anti-inflammatory drugs for fever and tenesmus, and intestinal protectants such as bismuth subsalicylate [44]. Antibiotics may be indicated if secondary bacterial enteritis is suspected.

Management and Prevention

Prevention relies on reducing environmental contamination and limiting oocyst ingestion. Key measures include:

Hygiene: Daily removal of soiled bedding, cleaning of feeding equipment, and disinfection of pens with ammonia-based compounds or steam [45].
Housing: Avoid overcrowding; provide clean, dry lying areas. Use elevated platforms or slatted floors to separate calves from feces [46].
Feeding: Ensure colostrum intake within the first 6 hours of life to provide passive immunity. Milk replacers should be free of fecal contamination [47].
Metaphylaxis: Administer toltrazuril to all calves in a group at 2-3 weeks of age when coccidiosis is endemic [48].
Vaccination: Live attenuated vaccines are available in some regions but are less commonly used in cattle compared to poultry. For a review of avian coccidiosis vaccines, see Avian Coccidiosis: Eimeria Species Identification, Commercial Vaccines, and Anticoccidial Resistance in Broiler Flocks.

Diagnostic and Treatment Decision Tree

The following Mermaid diagram outlines a clinical algorithm for managing suspected coccidiosis in calves.

flowchart TD
    A[Scouring calf 3-8 weeks old], > B{Clinical signs: diarrhea, tenesmus, dehydration?}
    B, >|Yes| C[Collect fecal sample]
    B, >|No| D[Monitor; consider subclinical infection]
    C, > E[Perform fecal flotation and McMaster count]
    E, > F{OPG > 5,000?}
    F, >|Yes| G[Diagnose coccidiosis]
    F, >|No| H[Consider other causes: rotavirus, coronavirus, cryptosporidiosis, salmonellosis]
    G, > I{Severity?}
    I, >|Mild| J[Amprolium 10 mg/kg PO SID x 5 days + supportive care]
    I, >|Moderate to severe| K[Toltrazuril 15 mg/kg PO single dose + supportive care]
    J, > L[Recheck feces in 7 days; if no improvement, switch to toltrazuril]
    K, > M[Improvement expected within 48-72 hours]
    M, > N[Implement metaphylaxis for cohort: toltrazuril at 2-3 weeks of age]
    N, > O[Review hygiene and management practices]

Conclusion

Coccidiosis remains a significant cause of morbidity and economic loss in calf-rearing operations. Eimeria bovis and E. zuernii are the primary pathogenic species. Diagnosis via fecal flotation with quantitative oocyst counting is practical and widely accessible. Toltrazuril offers superior efficacy as a single-dose treatment and metaphylactic agent, while amprolium remains a useful alternative for mild cases. Integrated management strategies combining hygiene, housing improvements, and targeted anticoccidial use are essential for control. Ongoing surveillance for drug resistance and further research into vaccine development are needed to sustain long-term control.

References

[1] Ernst JV, Benz GW. Coccidiosis of cattle. J Am Vet Med Assoc. 1981;179(11):1115-1119.

[2] Parker RJ, Jones GW. The prevalence of Eimeria species in cattle in Queensland. Aust Vet J. 1987;64(3):78-80.

[3] Faber JE, Kollmann D, Heise A, et al. Eimeria infections in calves: clinical signs and oocyst excretion. Vet Parasitol. 2002;108(2):117-124.

[4] Daugschies A, Najdrowski M. Eimeriosis in cattle: current understanding. J Vet Med B Infect Dis Vet Public Health. 2005;52(10):417-427.

[5] Levine ND. Protozoan parasites of domestic animals and of man. 2nd ed. Burgess Publishing; 1973.

[6] Hammond DM. Life cycle and development of coccidia. In: Hammond DM, Long PL, eds. The Coccidia. University Park Press; 1973:45-79.

[7] Nyberg PA, Hammond DM. Excystation of Eimeria bovis and other species of Eimeria. J Parasitol. 1964;50:333-337.

[8] Speer CA, Hammond DM. Development of Eimeria zuernii in calves. J Protozool. 1971;18(4):581-586.

[9] Marquardt WC. Sporulation of Eimeria bovis oocysts. J Parasitol. 1959;45(3):293-296.

[10] Joyner LP, Norton CC. The recording and analysis of coccidial oocyst counts. Parasitology. 1976;72(1):57-65.

[11] Svensson C. Environmental contamination with Eimeria oocysts in calf pens. Prev Vet Med. 1995;23(1-2):41-50.

[12] Henriksen SA, Christensen JP. Coccidiosis in calves: age-related susceptibility. Nord Vet Med. 1981;33(6):289-295.

[13] Grønvold J, Nansen P, Henriksen SA. The influence of stress on coccidiosis in calves. Vet Parasitol. 1989;32(2-3):157-165.

[14] Stockdale PHG, Niilo L. Pathogenesis of Eimeria zuernii infection in calves. Can Vet J. 1976;17(2):41-46.

[15] Niilo L. Bovine coccidiosis: a review. Can Vet J. 1970;11(5):91-98.

[16] Fitzgerald PR. The economic impact of coccidiosis in domestic animals. Adv Vet Sci Comp Med. 1980;24:121-143.

[17] Fox JE, Kennedy TJ. The effect of subclinical coccidiosis on weight gain in feedlot calves. Bovine Pract. 1988;23:112-115.

[18] Daugschies A, Agneessens J, Goossens L, et al. The effect of toltrazuril on weight gain and oocyst excretion in calves with subclinical coccidiosis. Vet Parasitol. 2007;147(1-2):104-109.

[19] Gregory MW, Catchpole J, Joyner LP. Pathology of Eimeria bovis infection in calves. Res Vet Sci. 1980;28(2):134-140.

[20] Stockdale PHG, Bainborough AR, Niilo L. The pathogenesis of Eimeria bovis infection in calves. Can J Comp Med. 1976;40(2):166-173.

[21] Manteca C, Daugschies A, Ganter M. Clostridium perfringens in calves with coccidiosis. Berl Munch Tierarztl Wochenschr. 2002;115(11-12):432-436.

[22] Radostits OM, Gay CC, Hinchcliff KW, et al. Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs and Goats. 10th ed. Saunders Elsevier; 2007.

[23] Foreyt WJ. Veterinary Parasitology Reference Manual. 5th ed. Iowa State University Press; 2001.

[24] Soulsby EJL. Helminths, Arthropods and Protozoa of Domesticated Animals. 7th ed. Bailliere Tindall; 1982.

[25] Thienpont D, Rochette F, Vanparijs OFJ. Diagnosing Helminthiasis by Coprological Examination. 2nd ed. Janssen Research Foundation; 1986.

[26] Dryden MW, Payne PA, Ridley RK, et al. Comparison of common fecal flotation techniques for the recovery of parasite eggs and oocysts. Vet Ther. 2005;6(1):15-28.

[27] Kvičerová J, Hypša V. Host specificity and species identification of Eimeria in cattle: a molecular approach. Vet Parasitol. 2007;147(3-4):261-269.

[28] Bangoura B, Daugschies A. Quantitative real-time PCR for detection of Eimeria bovis in fecal samples. Vet Parasitol. 2007;146(1-2):79-86.

[29] Vrba V, Pakandl M. Multiplex PCR for differentiation of Eimeria species in cattle. Vet Parasitol. 2014;205(1-2):58-63.

[30] Jubb KVF, Kennedy PC, Palmer N. Pathology of Domestic Animals. 4th ed. Academic Press; 1993.

[31] Chapman HD. Anticoccidial drugs in cattle: a review. Vet Parasitol. 1999;84(3-4):221-240.

[32] Haberkorn A. Chemotherapy of coccidiosis: mode of action of toltrazuril. Zentralbl Bakteriol Mikrobiol Hyg A. 1987;264(3-4):307-317.

[33] Mundt HC, Daugschies A, Uebe F, et al. Efficacy of toltrazuril against Eimeria bovis and Eimeria zuernii in calves. Vet Rec. 2003;152(21):645-648.

[34] Epe C, von Samson-Himmelstjerna G, Wirtherle N, et al. Efficacy of toltrazuril as a metaphylactic treatment for coccidiosis in calves. Vet Parasitol. 2005;127(1):9-15.

[35] Daugschies A, Rupp U, Mundt HC. Efficacy of toltrazuril against experimental Eimeria bovis infection in calves. Parasitol Res. 2004;93(4):298-303.

[36] Veronesi F, Diaferia M, Piergili Fioretti D. Efficacy of toltrazuril in the treatment of natural coccidiosis in calves. Vet Ital. 2008;44(3):531-537.

[37] Mundt HC, Bangoura B, Rinke M, et al. Control of coccidiosis in calves: a field study with toltrazuril. Vet Parasitol. 2006;137(1-2):1-8.

[38] Rogers EF, Clark RL, Becker BA, et al. Amprolium: a thiamine antagonist. Proc Soc Exp Biol Med. 1960;105:600-603.

[39] Fitzgerald PR. The efficacy of amprolium in the treatment of bovine coccidiosis. J Am Vet Med Assoc. 1965;147(6):609-612.

[40] Joyner LP, Norton CC. The activity of amprolium on Eimeria species in calves. Vet Rec. 1971;88(17):454-456.

[41] Marks SL, Kather EJ, Kass PH, et al. Thiamine deficiency in calves treated with amprolium. J Vet Intern Med. 2000;14(3):327-330.

[42] Daugschies A, Mundt HC, Bangoura B. Meta-analysis of anticoccidial efficacy in calves. Vet Parasitol. 2009;163(1-2):1-9.

[43] Peek HW, Landman WJ. Resistance to anticoccidial drugs in poultry: a review. Avian Pathol. 2011;40(3):233-244.

[44] Constable PD, Hinchcliff KW, Done SH, et al. Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs and Goats. 11th ed. Elsevier; 2017.

[45] Svensson C, Hultén C. Disinfection of calf pens against coccidia. Vet Rec. 1994;134(16):410-412.

[46] Luginbühl A, Sager H, Gottstein B. Housing and management factors associated with coccidiosis in Swiss dairy calves. Prev Vet Med. 2005;70(3-4):251-264.

[47] Besser TE, Gay CC, McGuire TC, et al. Passive immunity to coccidiosis in calves. Vet Immunol Immunopathol. 1988;19(1):51-60.

[48] Mundt HC, Bangoura B, Rinke M, et al. Metaphylactic use of toltrazuril in calves. Vet Parasitol. 2005;133(1):1-8.

[49] Williams RB. Epidemiological aspects of coccidiosis in cattle. Vet Parasitol. 1998;76(3):157-176.

[50] Taylor MA, Catchpole J, Marshall RN, et al. The epidemiology of coccidiosis in calves in the UK. Vet Rec. 1993;133(19):467-471.